Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Kintara Therapeutics, Inc (KTRA)  
$0.08 0.00 (0.00%) as of 4:30 Fri 11/11


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 1,680,000
Market Cap: 141.29(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.0841 - $0.0841
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kintara Therapeutics is a clinical stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. Co.'s two primary candidates are: VAL-083, a validated, DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late-stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 191
  Page 8 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bacha Jeffrey CEO and PRESIDENT   •       •       •   2014-02-13 4 B $0.80 $4,000 D/D 5,000 27,000 3.15     -
   Bell John K Director   –       •      –    2014-02-11 4 B $0.83 $7,504 D/D 9,000 19,000 2.39     -
   Toth Robert Joseph Jr Director   –       •      –    2014-02-05 4 B $0.88 $7,920 D/D 9,000 18,500 2.39     -
   Toth Robert Joseph Jr Director   –       •      –    2014-01-31 4 B $0.87 $1,740 D/D 2,000 9,500 2.31     -
   Toth Robert Joseph Jr Director   –       •      –    2014-01-29 4 B $0.91 $6,825 D/D 7,500 7,500 2.39     -
   Garner William J Director   –       •      –    2013-11-26 4 A $0.00 $0 I/I 5,000 10,000     -
   Garner William J Director   –       •      –    2013-09-20 4 B $1.00 $5,000 D/D 5,000 5,000 2.39     -
   Bell John K Director   –       •      –    2013-08-20 4 A $0.00 $0 I/I 10,000 10,000     -
   Bacha Jeffrey CEO and President   •       •       •   2013-08-05 4 A $0.00 $0 D/D 22,000 22,000     -
   Brown Dennis M Chief Scientific Officer   •       •       •   2013-08-02 4 A $0.00 $0 D/D 34,000 2,937,542     -
   Praill Scott CFOOfficer   •       –      –    2013-01-29 3 IO $0.00 $0 D/D 0 100,000     -
   Brown Dennis M Chief Scientific OfficerOffice   •       •       •   2013-01-25 3 IO $0.00 $0 I/I 0 2,903,542     -
   Fuguet Howard K 10% Owner   –       –       •   2013-01-25 3 IO $0.00 $0 D/D 0 1,250,000     -
   Bahouth Donald G. 10% Owner   –       –       •   2013-01-25 3 IO $0.00 $0 D/D 0 1,042,500     -
   Vollintine Raymond L. 10% Owner   –       –       •   2013-01-25 3 IO $0.00 $0 I/I 0 515,500     -
   Vollintine Raymond L. 10% Owner   –       –       •   2013-01-25 3 IO $0.00 $0 D/D 0 500,000     -

  191 Records found
  1  2  3  4  5  6  7  8    
  Page 8 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed